RAST test
WikiDoc Resources for RAST test |
Articles |
---|
Most recent articles on RAST test |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on RAST test at Clinical Trials.gov Clinical Trials on RAST test at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on RAST test
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on RAST test Discussion groups on RAST test Directions to Hospitals Treating RAST test Risk calculators and risk factors for RAST test
|
Healthcare Provider Resources |
Causes & Risk Factors for RAST test |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
A RAST test (short for radioallergosorbent test) is a blood test used to determine what a person is allergic to. This is different from a skin allergy test, which determines allergy by the reaction of a person's skin to different substances. For assessing the presence of specific IgE antibodies, allergy skin testing, when possible, is the preferred method in comparison with various in vitro tests because it is more sensitive and specific, simpler to use, and less expensive (http://www.mayoclinicproceedings.com/inside.asp?AID=3978&UID=). [1]
A RAST test, using a person's extracted blood, detects the amount of IgE that reacts specifically with suspected or known allergens. IgE is the antibody associated with the allergic response: if a person exhibits a high level of IgE directed against pollen, the test may indicate the person is allergic to pollen (or pollen-like) proteins. It is worth noting that a person who has outgrown an allergy may still have a positive IgE years after exposure. Because there are other tests that help with confirmation, results are best interpreted by a doctor.
The RAST was introduced in the 1970's and replaced by a superior test in 1989. Advantages of the new test range from: improved sensitivity without loss of specificity, to excellent reproducibility across the full measuring range of the calibration curve. In general, this method of blood testing (in-vitro, out of body) vs skin-prick testing (in-vivo, in body) has a major advantage: it is not always necessary to remove the patient from an anthihistamine medication regimen, and if the skin conditions (such as eczema) are so widespread that allergy skin testing can not be done, RAST tests don't affect results, it's more invasive (one venipuncture needle versus many skin pricks with a plastic device).
History
The market-leading RAST methodology was invented and marketed in 1974 by Pharmacia Diagnostics AB, Uppsala, Sweden, and the acronymn RAST is actually a brand name. In 1989, Pharmacia Diagnostics AB replaced it with a superior test named the ImmunoCAP Specific IgE blood test, which literature may also describe as: CAP RAST, CAP FEIA (fluorenzymeimmunoassay), and Pharmacia CAP. A review of applicable quality assessment programs shows that this new test has replaced the original RAST in approximately 80% of the world's commercial clinical laboratories, where specific IgE testing is performed. The newest version, the ImmunoCAP® Specific IgE 0-100, is the only specific IgE assay to receive FDA approval to quantitatively report to its detection limit of 0.1kU/l. This clearance is based on the CLSI/NCCLS-17A Limits of Detection and Limits of Quantitation, October 2004 guideline.
RAST often are used to test for allergies when: • a physician advises against the discontinuation of medications that can interfere with test results or cause medical complications; • a patient suffers from severe skin conditions such as widespread eczema or psoriasis; or • a patient has such a high sensitivity level to suspected allergens that any administration of those allergens might result in potentially serious side effects.
References
- ↑ Ten, R (1995). "Allergy Skin Testing". Mayo Clin Proc. 5 (70): 783–4. pmid 7630219.
External links
- Ten RM, Klein JS, Frigas E (1995). "Allergy skin testing". Mayo Clin. Proc. 70 (8): 783–4. PMID 7630219.
- A discussion by world renowned experts on the relative value of RAST testing from the American Academy of Allergy, Asthma and Immunology (AAAAI), the largest professional medical specialty organization representing allergists, clinical immunologists, allied health professionals, and other physicians with a special interest in allergy
- ImmunoCAP® articles, disease management data, product info from the manufacturer that markets this product:
- Short FAQ's: How a RAST test is performed, results, when ordered:
- A glossary of allergy testing information regarding RAST
References
External links
- Radioallergosorbent+Test at the US National Library of Medicine Medical Subject Headings (MeSH)